SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design
<|reference_start|>SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design: Drug discovery is a complex and resource-intensive process, with significant time and cost investments required to bring new medicines to patients. Recent advancements in generative machine learning (ML) methods offer promising avenues to accelerate early-stage drug discovery by efficiently exploring chemical space. This paper addresses the gap between in silico generative approaches and practical in vitro methodologies, highlighting the need for their integration to optimize molecule discovery. We introduce SynthFormer, a novel ML model that utilizes a 3D equivariant encoder for pharmacophores to generate fully synthesizable molecules, constructed as synthetic trees. Unlike previous methods, SynthFormer incorporates 3D information and provides synthetic paths, enhancing its ability to produce molecules with good docking scores across various proteins. Our contributions include a new methodology for efficient chemical space exploration using 3D information, a novel architecture called Synthformer for translating 3D pharmacophore representations into molecules, and a meaningful embedding space that organizes reagents for drug discovery optimization. Synthformer generates molecules that dock well and enables effective late-stage optimization restricted by synthesis paths.<|reference_end|>
@article{jocys2024synthformer:,
    title={SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for
  Ligand-Based Drug Design},
    author={Zygimantas Jocys, Henriette M.G. Willems, Katayoun Farrahi},
    journal={arXiv preprint arXiv:2410.02718},
    year={2024},
    archivePrefix={arXiv},
    eprint={2410.02718},
    primaryClass={cs.LG}
}